Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD.
Zhou XD, Lian LY, Chen QF, Kim SU, Cheuk-Fung Yip T, Petta S, Nakajima A, Tsochatzis E, Shi J, Chan WK, Boursier J, Bugianesi E, Yilmaz Y, Hagström H, Romero-Gomez M, Alswat K, Calleja JL, Takahashi H, de Lédinghen V, Shalimar, Castéra L, Sanyal AJ, Goh GB, Newsome PN, Fan JG, Lai M, Aggarwal S, Kechagias S, Hiasa Y, Dayal B, Zhang Z, George J, El-Kassas M, Chen J, You H, Abu Dayyeh BK, Sheng H, Adams LA, Wang J, He F, Liang H, Yang YF, Chi X, Zhong B, Bi Y, Mi Y, Zhu Y, Bai R, Zhang J, Wang B, Song J, Deng H, Xie Q, Bai L, Xin Y, Xie W, Li J, Fournier-Poizat C, Zoncapè M, Xia T, Ju S, Wu C, Lee HW, Wong GL, Armandi A, Shang Y, Pennisi G, Llop E, Yoneda M, de Saint-Loup M, Canivet CM, Lara-Romero C, Gallego-Durán R, Carrillo-Fernández P, Asgharpour A, Teh KK, Mahgoub S, Chan MS, Lin H, Liu WY, Song SJ, Al-Hamoudi WK, Isoda H, Miyake T, Satapathy SK, Li M, Sharma K, Emadeldeen M, Zhou L, Tong X, Bazerbachi F, Fan X, Xiao H, Ye J, Xu L, Wang X, Targher G, Byrne CD, Shapiro MD, Tacke F, Wai-Sun Wong V, Zheng MH; VCTE-Prognosis Study Group; Paired Liver Biopsy Group.
Zhou XD, et al. Among authors: xia t.
J Hepatol. 2026 Feb;84(2):254-265. doi: 10.1016/j.jhep.2025.08.017. Epub 2025 Aug 23.
J Hepatol. 2026.
PMID: 40854336
